These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30366726)

  • 1. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger.
    Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
    Radiother Oncol; 2019 Mar; 132():230-235. PubMed ID: 30366726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma.
    Shiba S; Shibuya K; Okamoto M; Okazaki S; Komatsu S; Kubota Y; Nakano T; Ohno T
    Radiat Oncol; 2020 Aug; 15(1):195. PubMed ID: 32795340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.
    Shiba S; Abe T; Shibuya K; Katoh H; Koyama Y; Shimada H; Kakizaki S; Shirabe K; Kuwano H; Ohno T; Nakano T
    BMC Cancer; 2017 Nov; 17(1):721. PubMed ID: 29115938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study.
    Shibuya K; Ohno T; Terashima K; Toyama S; Yasuda S; Tsuji H; Okimoto T; Shioyama Y; Nemoto K; Kamada T; Nakano T;
    Liver Int; 2018 Dec; 38(12):2239-2247. PubMed ID: 30240527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
    Kasuya G; Kato H; Yasuda S; Tsuji H; Yamada S; Haruyama Y; Kobashi G; Ebner DK; Okada NN; Makishima H; Miyazaki M; Kamada T; Tsujii H;
    Cancer; 2017 Oct; 123(20):3955-3965. PubMed ID: 28662297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
    Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
    BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
    Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.
    Habermehl D; Debus J; Ganten T; Ganten MK; Bauer J; Brecht IC; Brons S; Haberer T; Haertig M; Jäkel O; Parodi K; Welzel T; Combs SE
    Radiat Oncol; 2013 Mar; 8():59. PubMed ID: 23497349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of 4 Fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: A Prospective Study.
    Shibuya K; Katoh H; Koyama Y; Shiba S; Okamoto M; Okazaki S; Araki K; Kakizaki S; Shirabe K; Ohno T
    Liver Cancer; 2022 Jan; 11(1):61-74. PubMed ID: 35222508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
    Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
    Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma.
    Bae SH; Park HC; Lim DH; Lee JA; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e603-7. PubMed ID: 22208963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
    Yu JI; Park HC; Lim DH; Paik SW
    Cancer Res Treat; 2016 Apr; 48(2):574-82. PubMed ID: 26194367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
    Apisarnthanarax S; Bowen SR; Combs SE
    Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
    Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours].
    Le Bon M; Lapeyre M; Moreau J; Bellière-Calandry A; Pezet D; Abergel A; Bellini R; Kwiatkowski F; Verrelle P; Martin F; Benoît C
    Cancer Radiother; 2019 Sep; 23(5):385-394. PubMed ID: 31300328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702".
    Kawamura H; Kubo N; Sato H; Mizukami T; Katoh H; Ishikawa H; Ohno T; Matsui H; Ito K; Suzuki K; Nakano T;
    BMC Cancer; 2020 Jan; 20(1):75. PubMed ID: 32000716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum.
    Shinoto M; Yamada S; Okamoto M; Shioyama Y; Ohno T; Nakano T; Nemoto K; Isozaki Y; Kawashiro S; Tsuji H; Kamada T
    Radiother Oncol; 2019 Mar; 132():236-240. PubMed ID: 30360998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
    Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
    BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.